Latest News about GILD
Recent news which mentions GILD
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  December 01, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Thursday
   
  
  
  December 01, 2022
  From Benzinga
 
   The Top Healthcare Stocks to Buy With $100
   
  
  
  December 01, 2022
  From Motley Fool
 
   These 3 Stocks Are Rallying While the Rest of the Market Plunges
   
  
  
  November 30, 2022
  From Motley Fool
 
   Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures
   
  
  
  November 28, 2022
  From Benzinga
 
   VALQ Offers Quality-Focused Value Approach
   
  
  
  November 22, 2022
  From ETF Trends
 
   2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
   
  
  
  November 22, 2022
  From Motley Fool
 
   Stocks That Hit 52-Week Lows On Monday
   
  
  
  November 21, 2022
  From Benzinga
 
   Jim Simons 'The Man Who Solved The Market' Sold 3 Healthcare Dividend Payers, But Upped Stake In This One By 153%
   
  
  
  November 20, 2022
  From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  November 17, 2022
  From Benzinga
 From Benzinga
 
   Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
   
  
  
  November 16, 2022
  From Benzinga
 
   Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?
   
  
  
  November 14, 2022
  From Benzinga
 
   2 Top Biotech Stocks to Buy in November
   
  
  
  November 12, 2022
  From Motley Fool
 
   Novavax stock rallies, even as company offers a dimmer sales forecast for vaccines
   
  
  
  November 08, 2022
  From MarketWatch
 
   Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
   
  November 08, 2022
  Tickers 
   GILD
  
  
  From Benzinga
 
   Why Shares of Gilead Sciences Rose 27.20% in October
   
  November 08, 2022
  Tickers 
   GILD
  
  
  From Motley Fool
 
   US Supreme Court Throws Out Bristol Myers Appeal On Cancer-Drug Related Patent With Gilead
   
  
  
  November 07, 2022
  From Benzinga
 
   3 No-Brainer Dividend Stocks to Buy in November
   
  
  
  November 05, 2022
  From Motley Fool
 
   G1 Therapeutics Says Its Lead Candidate May Cut Adverse Events Of Gilead's Breast Cancer Drug
   
  
  
  November 02, 2022
  From Benzinga
 
   9 Health Care Stocks Whale Activity In Today's Session
   
  
  
  November 01, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
